CD47 and B-cell chronic lymphocytic leukemia: Grouping patient samples based on CD47 mRNA expression levels, investigators showed improved overall survival in patients with CD47 low tumors, especially diffuse large B cell lymphoma (DLBCL), B cell chronic lymphocytic leukemia, and mantle cell lymphoma subsets [63].